Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/47395 https://doi.org/10.1016/j.psychres.2017.03.049 |
Resumo: | In this prospective study, we examined new-onset major depressive disorder (MDD) and the differential expression of depressive symptoms in a sample of 132 HCV mono-infected and 40 HIV/HCV co-infected patients initiating pegylated interferon-based treatment, including protease inhibitor therapy. The semi-structured clinical interview (SCID-I) was used to assess MDD. Severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Of the total sample, 60 patients (34.9%) developed SCID-I defined MDD during antiviral treatment. The proportion of HCV mono- and HIV/HCV patients developing MDD during treatment was not significantly different (37.9% vs. 25%; p=0.185). In both groups, there was a significant increase in HAMD total score from baseline to week 4, and a significant decrease between week 24 and 6 months post-treatment cessation. The greatest increase was observed in the symptoms of the neurovegetative syndrome. HCV mono-infected patients reported higher scores than co-infected patients, particularly impaired activity and somatic symptoms, but the differences were only significant at week 12. The finding that co-infected patients appear less vulnerable to the development of depressive symptoms during HCV treatment than HCV mono-infected patients warrants further exploration, including a thorough analysis of the biological and psychosocial factors associated with this emergence. |
id |
RCAP_6c20ce6f0c19dc44250d4f05473cba97 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/47395 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis CAdultAntiviral AgentsCoinfectionDepressive Disorder, MajorDrug Therapy, CombinationFemaleHIV InfectionsHepacivirusHepatitis CHumansInterferon-alphaMaleMiddle AgedProspective StudiesRibavirinIn this prospective study, we examined new-onset major depressive disorder (MDD) and the differential expression of depressive symptoms in a sample of 132 HCV mono-infected and 40 HIV/HCV co-infected patients initiating pegylated interferon-based treatment, including protease inhibitor therapy. The semi-structured clinical interview (SCID-I) was used to assess MDD. Severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Of the total sample, 60 patients (34.9%) developed SCID-I defined MDD during antiviral treatment. The proportion of HCV mono- and HIV/HCV patients developing MDD during treatment was not significantly different (37.9% vs. 25%; p=0.185). In both groups, there was a significant increase in HAMD total score from baseline to week 4, and a significant decrease between week 24 and 6 months post-treatment cessation. The greatest increase was observed in the symptoms of the neurovegetative syndrome. HCV mono-infected patients reported higher scores than co-infected patients, particularly impaired activity and somatic symptoms, but the differences were only significant at week 12. The finding that co-infected patients appear less vulnerable to the development of depressive symptoms during HCV treatment than HCV mono-infected patients warrants further exploration, including a thorough analysis of the biological and psychosocial factors associated with this emergence.2017info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/47395http://hdl.handle.net/10316/47395https://doi.org/10.1016/j.psychres.2017.03.049engFialho, R., Pereira, M., Harrison, N., Rusted, J., & Whale, R. (2017). Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C. Psychiatry Research, 253, 150-157. doi:10.1016/j.psychres.2017.03.049http://www.psy-journal.com/article/S0165-1781(16)31874-1/fulltextFialho, RenataPereira, MarcoHarrison, NeilRusted, JenniferWhale, Richardinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2020-05-25T02:24:07Zoai:estudogeral.uc.pt:10316/47395Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:48:33.370004Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C |
title |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C |
spellingShingle |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C Fialho, Renata Adult Antiviral Agents Coinfection Depressive Disorder, Major Drug Therapy, Combination Female HIV Infections Hepacivirus Hepatitis C Humans Interferon-alpha Male Middle Aged Prospective Studies Ribavirin |
title_short |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C |
title_full |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C |
title_fullStr |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C |
title_full_unstemmed |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C |
title_sort |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C |
author |
Fialho, Renata |
author_facet |
Fialho, Renata Pereira, Marco Harrison, Neil Rusted, Jennifer Whale, Richard |
author_role |
author |
author2 |
Pereira, Marco Harrison, Neil Rusted, Jennifer Whale, Richard |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Fialho, Renata Pereira, Marco Harrison, Neil Rusted, Jennifer Whale, Richard |
dc.subject.por.fl_str_mv |
Adult Antiviral Agents Coinfection Depressive Disorder, Major Drug Therapy, Combination Female HIV Infections Hepacivirus Hepatitis C Humans Interferon-alpha Male Middle Aged Prospective Studies Ribavirin |
topic |
Adult Antiviral Agents Coinfection Depressive Disorder, Major Drug Therapy, Combination Female HIV Infections Hepacivirus Hepatitis C Humans Interferon-alpha Male Middle Aged Prospective Studies Ribavirin |
description |
In this prospective study, we examined new-onset major depressive disorder (MDD) and the differential expression of depressive symptoms in a sample of 132 HCV mono-infected and 40 HIV/HCV co-infected patients initiating pegylated interferon-based treatment, including protease inhibitor therapy. The semi-structured clinical interview (SCID-I) was used to assess MDD. Severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Of the total sample, 60 patients (34.9%) developed SCID-I defined MDD during antiviral treatment. The proportion of HCV mono- and HIV/HCV patients developing MDD during treatment was not significantly different (37.9% vs. 25%; p=0.185). In both groups, there was a significant increase in HAMD total score from baseline to week 4, and a significant decrease between week 24 and 6 months post-treatment cessation. The greatest increase was observed in the symptoms of the neurovegetative syndrome. HCV mono-infected patients reported higher scores than co-infected patients, particularly impaired activity and somatic symptoms, but the differences were only significant at week 12. The finding that co-infected patients appear less vulnerable to the development of depressive symptoms during HCV treatment than HCV mono-infected patients warrants further exploration, including a thorough analysis of the biological and psychosocial factors associated with this emergence. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/47395 http://hdl.handle.net/10316/47395 https://doi.org/10.1016/j.psychres.2017.03.049 |
url |
http://hdl.handle.net/10316/47395 https://doi.org/10.1016/j.psychres.2017.03.049 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Fialho, R., Pereira, M., Harrison, N., Rusted, J., & Whale, R. (2017). Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C. Psychiatry Research, 253, 150-157. doi:10.1016/j.psychres.2017.03.049 http://www.psy-journal.com/article/S0165-1781(16)31874-1/fulltext |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799133763856236544 |